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The mother enzyme of RNase T, was co-crystallized with its natural product, 3’-GMP at pH 4.0. The X-ray 
structure of this complex was refined with 2432 reflections in the 5.4-2.6 A range using a stereochemical 
restrained method (conventional R=27.4%). The overall polypeptide chain folding is very similar in the 
secondary structure elements to the RNase T, in the complex with 2’-GMP crystallized also at pH 4.0, but 
larger conformational changes occur in the loop regions. The base recognition scheme is identical in both 
complexes but in RNase T,.3’-GMP, the ribose phosphate is not seen in the electron density, probably 
due to static disorder. 
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1. INTRODUCTION 
In the last 3 years, the crystal structures of 
several prokaryotic (bacterial) and eukaryotic 
(fungal) ribonucleases (RNases) have been deter- 
mined by X-ray diffraction methods. The studies 
suggest hat all these enzymes belong to the same 
family because the active site is formed by a com- 
parable folding of the polypeptide chain into a 
4-stranded, antiparallel P-pleated sheet [l]. In the 
case of one of these RNases, RNase Ti, the com- 
plex with 2’ -guanylic acid (2’ -GMP) was in- 
vestigated for an isoenzyme (where Gln is ex- 
changed with Lys25 in the mother enzyme), 
crystallized at pH 5.3 (1) [2,3], and for the mother 
enzyme, crystallized at pH 4.0 (2) [4]. 
In both crystal structures, 2 ’ -GMP adopts the 
same syn conformation and the base is sandwiched 
between the phenolic side chains of Tyr42 and 
Tyr45. Moreover, in 1 two hydrogen bonds are 
formed between guanine 06, NiH and peptide 
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Disordered ribose 
groups of Asn43NH, Asn44CO whereas in 2, 
hydrogen bonding involves in addition guanine Nz, 
NT and two other peptide groups (Asn44NH, 
Asn98CO) as well as the side chains of Glu46, 
Asn43. The ribose phosphate group is bound to the 
active site (consisting of His40, Glu58, Arg77 and 
His92) by one His40.. . phosphate hydrogen bond 
in 1, whereas in 2, the phosphate interacts with 
Tyr38, Glu58, Arg77. These differences in 
2’-GMP binding are not due to the LysZS-Gln 
substitution in mother and isoenzyme complexes 2 
and 1 but are associated with the change in pH. 
The pH 5.3 isoenzyme-2 ’ -GMP structure 1 ap- 
pears to correspond to an active complex whereas 
the mother enzyme-2’-GMP crystallized at pH 4.0, 
2 represents an inactive complex [4]. 
To elucidate the catalytic mechanism of RNase 
Ti, the complex with the real reaction product, 
3 ‘-GMP, is better suited than the inhibitor 
2’-GMP. Therefore, this paper describes the co- 
crystallization (at pH 4.0) of the mother enzyme of 
RNase Ti with 3’-GMP and the structural features 
of the complex as determined by X-ray diffraction 
methods at 2.6 A resolution. 
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2. EXPERIMENTAL 
The mother enzyme of RNase Tr used for this 
study was purified from Taka-diastase [5]. 
Crystallization of the RNase Tr-3 ’ -GMP complex 
(3) was carried out by a vapor diffusion method 
with 2-methyl-2,Cpentanediol under the same con- 
ditions (pH 4.0) described for the low pH form of 
the RNase Tr-2’-GMP complex (2). The obtained 
crystals display orthorhombic space group P212121 
with cell dimensions a = 47.58(l), b = 50.92(l), 
c = 40.32(l) A. These parameters differ by no 
more than 2% (for the a-axis) from those reported 
for the RNase Tr-2’-GMP complexes 1 and 2 
[2-41, suggesting that the crystal structures are 
near-isomorphous. To determine whether the 
crystal of 3 contains 3 ’ -GMP, the crystals were re- 
dissolved and analyzed by paper electrophoresis 
(pH 8.0). The molar ratio of 3 ’ -GMP to RNase Tr 
in the crystal of 3, 0.9, was estimated by the UV 
absorption ratio of 258 to 280 nm. 
X-ray intensity data were collected on an 
automated Rigaku-Denki AFC-5 4-circle diffrac- 
tometer up to 2.2 A resolution using 4 crystals. 
After absorption correction [6], scaling [7,8] and 
merging of overlapping and symmetry equivalent 
reflections (Rmerge = 5.4%), 4063 statistically 
significant reflections above the 4a(Fo) threshold 
were obtained. Assuming that the crystal structure 
of 3 is roughly isomorphous to that of 2, at least 
at low resolution, an initial phase set in the 10-3 A 
range was calculated from a structure containing 
only the main-chain atoms of 2, yielding an R fac- 
tor of 44%. The structure was refined by a 
stereochemically restrained least-squares pro- 
cedure [9] followed by manual revision of the pep- 
tide main-chain and/or by the addition of newly 
assigned side-chain and solvent atoms using 2Fo- 
Fc and Fo-Fc syntheses. The current structure 
model consisting of 776 atoms (out of 805 atoms) 
of the complex and of 24 solvent atoms gives an R 
factor of 27.4% for 2432 reflections in the 
5.4-2.6 A resolution range. 
3. RESULTS AND DISCUSSION 
In the structure model of the RNase 
Tr-3 ’ -GMP complex 3, 17 atoms could not be 
located with confidence because they belong to the 
more flexible N-terminus and to the solvent- 
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Fig. 1. &-drawings of the polypeptide chain folding of 
the RNase Tr-3’-GMP complex 3 (solid lines) and of 
the RNase T,-2’-GMP complex 2(open lines). ‘N’ and 
‘C’ represent the N- and C-termini, respectively. The 
two structures can be superimposed with r.m.s. 
deviation of C, distances of 0.72 A. Larger deviations 
are found at the external loop (residues 69-74) in which 
the main chain conformations are not well determined in 
both complexes. 
exposed side chains of Asp3, Gln25, Glu3 1, Lys41, 
Asp49. 
As shown in fig. 1, the overall polypeptide 
folding of 3 is similar to that of 2. The architecture 
of the enzyme in the two complexes is retained with 
r.m.s. deviation of only 0.38 A for 43 distances 
between corresponding C, atoms in the core region 
including the a-helix (residues 13-28), the 
4-stranded anti-parallel P-sheet (residues 38-42, 
55-60,76-80 and 86-91) and the guanine binding 
site, residues 43-46. Some larger deviations occur 
in the loop regions, residues 32-38 and 47-55 and, 
even more pronounced, in the region 69-74. These 
structural (conformational) changes can be 
associated with the binding of 3 ’ -GMP instead of 
2’-GMP, or they could be due to the differences in 
crystal packing which are indicated by the change 
in a-axis dimensions of about 1 A. 
Concerning the 3 ‘-GMP molecule bound to 
RNase Tr, the electron density for the guanine base 
and for ribose atom Cr I is well defined and can be 
clearly interpreted, as indicated in fig.2. The in- 
teractions between guanine and RNase Tr are iden- 
tical to those observed in complex 2. In contrast to 
this complex, however, there is no interpretable 
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Fig.2. The guanine base recognition site found in the 
RNase Tr-3’GMP complex 3. The guanine base is 
bound to the enzyme by 4 hydrogen bonds, Asn44N- 
H . . .06&a, Asn98CO.. .H-NZGua, Asn43ND2..  
N7Gua and Glu46OEl.. .H-NlGua (dashed lines), and is 
sandwiched between the phenohc side chains of Tyr42 
and Tyr45. The same geometry was observed in 2 [4] but 
is different in 1 [2,3]. Guanine and peptide main chain 
bonds are indicated by solid lines, side chains by open 
lines. 
electron density for the ribose moiety and for the 
3 ‘-phosphate group. 
Because paper electrophoresis had indicated that 
the ribose was not hydrolyzed under crystallization 
conditions (pH 4.0), we conclude that the ribose 
3 ‘-phosphate moiety of 3 ’ -GMP is disordered in 
the complex with RNase Tr. This disorder can be 
static, if the ribose 3 ‘-phosphate is bound in dif- 
ferent RNase Tr molecules in different, yet closely 
related sites (due to rotations about the giycosyl 
Cr,-Ng bond), and the overall electron density is 
smeared out so much that ribose and phosphate 
groups are not clearly seen; it is also possible that 
at pH 4.0 some sites are only half protonated and 
give rise to different hydrogen-bonding schemes. 
On the other hand, it could well be that the 
disorder is dynamic and that the RNase Tr reaction 
which involves continuous formation of guano- 
sine-2’ ,3 ’ -cyclic phosphate and its hydrolysis to 
3 ‘-GMP, etc., takes place. This process should, 
however, be associated with movements of the 
active site residues His40, Glu58, Arg77, His92, 
Fig.3. A view of the active site residues in the RNase 
Tr-3 ’ -GMP complex 3 (solid lines) superimposed on 
those in the RNase T,-2’-GMP complex 2 (open lines). 
Due to a large conformational change of His40 which 
involves rotations about the &C,T and Co-C, bonds, 
the imidazole group does not form a hydrogen bond 
with Glu58 in 3 whereas this interaction occurs in 2 
(dashed line). 
which are all clearly seen in the electron density 
map (fig.3). Moreover, the pH 4.0 is close to an in- 
active enzyme so that static disorder is more 
probable. 
This finding is surprising because model 
building studies where 3 ’ -GMP was fitted manuaf- 
ly in the active site of the structure of RNase Tr 
(determined at pH 5.3) suggested that 3’-GMP 
would fit ideally, with only minor rotation about 
the glycosyl link relative to 2’ -GMP [3]. In that 
case, ionized Glu58 would interact with the ribose 
Oz,H (and activate it), and His92 would be in a 
position to hydrogen bond to the 3’-phosphate 
group. It appears that, as described for 2 [4], the 
protonation scheme at the active site is changed 
drastically at pH 4.0, and therefore the situation 
for the binding of 3’-GMP may be different com- 
pared with pH 5.3. 
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